Kisspeptin-10: What It Is and Its U.S. Regulatory Status

What is kisspeptin?

Kisspeptin is a family of natural peptides made from the KISS1 gene that act as a master switch for the reproductive hormone system. Kisspeptin-10, the shortest fully active fragment at ten amino acids, is not FDA-approved, and no FDA-approved product contains any form of kisspeptin.

Longer natural forms include kisspeptin-54, also called metastin, which is the main form circulating in human blood.

The KISS1 gene was first described in 1996 by researchers at Penn State's College of Medicine in Hershey, Pennsylvania, who were studying why some melanoma cells stop spreading. Its name is a nod to the town's famous chocolate Kisses.

What does kisspeptin do in the body?

Kisspeptin acts on a receptor called KISS1R, also known as GPR54, found on the brain cells that release gonadotropin-releasing hormone (GnRH). GnRH in turn controls the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which drive testosterone and estrogen production and fertility.

Its importance became clear in 2003, when researchers reported that people with inactivating changes in the GPR54 gene did not go through normal puberty, a condition called hypogonadotropic hypogonadism.

Human research

Kisspeptin has been given to people in research settings, mostly in small, closely monitored studies. In a 2011 study of healthy men in Edinburgh, kisspeptin-10 given into a vein rapidly raised LH levels, and a continuous infusion raised testosterone. Each step of the study involved only 4 to 6 men.

In a 2014 study at Imperial College London, a single administration of kisspeptin-54 (the longer form, not kisspeptin-10) was used to trigger egg maturation in 53 women having IVF. Researchers continue to study kisspeptin as a research tool and possible fertility medicine, but none of this work has produced an approved product.

U.S. regulatory status

Current status: Not FDA-approved.

Compounding: Unlike many peptides in this guide, kisspeptin-10 remains in Category 2 of the FDA's interim 503A lists, the group of bulk substances that raise significant safety risks. The FDA added it on September 29, 2023, and it was still listed in the FDA's May 14, 2026 update. At an FDA advisory committee meeting on October 29, 2024, where it was evaluated for secondary hypogonadism in men, members voted 11 to 0 against adding kisspeptin-10 to the 503A bulks list, citing a lack of convincing safety and efficacy data.

Documented safety information

The FDA's safety summary says compounded kisspeptin-10 may pose a risk of immunogenicity (an unwanted immune response) for certain routes of administration and may have complexities with peptide-related impurities. The FDA said it has no, or only limited, safety information for the proposed routes, so it lacks sufficient information to know whether the drug would cause harm in humans.

In its 2024 review, the FDA also described animal findings: in mice prone to atherosclerosis, a four-week continuous infusion of kisspeptin-10 sped up the buildup of fatty plaques in the aorta. The FDA said the relevance of this to people is unclear, and it found no studies of genetic toxicity, reproductive toxicity or cancer risk.

Sport

The World Anti-Doping Agency (WADA) 2026 Prohibited List names kisspeptin and its agonist analogues under class S2 as testosterone-stimulating peptides prohibited in males. They are prohibited at all times, in and out of competition.

Why Peptide Labs does not sell kisspeptin-10

Peptide Labs does not sell this compound. This page is general information, not medical advice. We are not a pharmacy, we do not supply, prepare or distribute kisspeptin-10 in any form, and nothing on this page should be read as an offer.

Because kisspeptin affects the hormone system that controls fertility, questions about it are best taken to a licensed healthcare provider, such as an endocrinologist or reproductive specialist, who knows your medical history.

Related reading

See the full list of compound profiles in the Peptide Guide. For a related compound that acts one step further along the same hormone chain, see our profile of gonadorelin, or read whether peptides are legal in the U.S.